Variables | Clinical pathway, n = 238 | No intervention, n = 238 | Between-group difference, OR (95% CI) | P-valuec |
---|---|---|---|---|
Information, advice, and support from the multidisciplinary team given to the patients (and with their consent, to the caregivers) | 204/204 (100) (98.2 to 0.0) | 115/133 (86.5) (81.2 to 92.3) | 1.16 (1.08 to 1.24) | < 0.001 |
Use of clinical protocols (see protocol) | 221/229 (96.5) (93.2 to 98.5) | 83/139 (59.7) (51.1 to 67.9) | 18.64 (8.14 to 44.31) | < 0.001 |
Use of CT/MRI brain scan within 48 hours of admission | 223/229 (97.4) (94.4 to 99.0) | 209/219 (95.4) (91.8 to 97.8) | 1.78 (0.58 to 5.61) | 0.31 |
Aspirin treatment within 48 hours of admission | 157/188 (83.5) (77.4 to 88.5) | 146/196 (74.5) (67.8 to 80.4) | 1.73 (1.02 to 2.75) | 0.03 |
Swallow screen test on day of admission | 211/213 (99.1) (96.6 to 99.9) | 83/95 (87.4) (79.0 to 93.3) | 15.25 (3.14 to 100.96) | < 0.001 |
Blood pressure assessment | 173/197 (87.8) (82.3 to 92.0) | 78/191 (40.8) (33.8 to 48.2) | 10.44 (6.06 to 18.10) | < 0.001 |
ECG/ECD within 24 hours of admission | 168/181 (92.8) (90.4 to 96.9) | 205/218 (94.0) (90.0 to 96.8) | 0.82 (0.35 to 1.94) | 0.69 |
Continuous monitoring within 48 hours of admission (see protocol) | 85/229 (37.1) (30.8 to 43.7) | 21/219 (9.6) (6.0 to 14.3) | 5.57 (3.21 to 9.73) | < 0.001 |
Before discharge total assessment (see protocol) | 200/215 (93.0) (89.4 to 96.3) | 176/200 (88.0) (85.1 to 93.9) | 1.82 (0.88 to 3.77) | 0.09 |
Use of discharge plan (and communication) | 73/214 (34.1) (25.9 to 38.3) | 41/200 (20.5) (13.8 to 24.5) | 2.01 (1.26 to 3.21) | < 0.01 |
Use of SIGN guideline-based discharge plan | 188/207 (90.8) (86.0 to 94.4) | 0 (0.0) (0.0 to 3.7) | 999.4 (137.0 to 20374.0) | < 0.001 |
Use of discharge summary and information (information pack) | 190/214 (88.8) (77.5 to 87.6) | 134/200 (67.0) (54.4 to 67.7) | 3.90 (2.26 to 6.67) | < 0.001 |
Before discharge assessment with FIM scale | 201/209 (96.2) (93.4 to 98.5) | 76/168 (45.2) (39.0 to 54.6) | 30.41 (13.49 to 71.24) | < 0.001 |
Follow-up assessment at 3 months with FIM scale | 82/86 (95.3) (89.9 to 98.9) | 9/29 (31.0) (16.1 to 50.0) | 45.56 (11.20 to 205.58) | < 0.001 |